psychiatrist.com logo

Longi​tudina​l Perspectives: Understanding the Lifetime​ Course of Schizophrenia

Experts on the treatment of schizophrenia participated in a recent roundtable meeting to discuss the neurobiology of schizophrenia over the longitudinal course of the disease. In these Brief Reports, the meeting participants summarize new insights in areas including cognitive impairment, early detection, and the genetic basis of the illness.

Robert B. Zipursky, MD

Robert B. Zipursky, MD

Department of Psychiatry and Behavioural Neurosciences,
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada

Richard S. E. Keefe, PhD

Richard S. E. Keefe, PhD

Duke University Medical Center,
Durham, North Carolina

Keith H. Nuechterlein, PhD

Keith H. Nuechterlein, PhD

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Geffen School of Medicine and Department of Psychology, University of California, Los Angeles

Philip D. Harvey, PhD

Philip D. Harvey, PhD

University of Miami Miller School of Medicine, Miami, Florida

Amy E. Pinkham, PhD

Amy E. Pinkham, PhD

Department of Psychology, Southern Methodist University, and the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas

Robert W. Buchanan, MD

Rimal B. Bera, MD

Department of Psychiatry and Human Behavior, University of California, Irvine

Alexander B. Niculescu, III, MD, PhD

Alexander B. Niculescu, III, MD, PhD

Department of Psychiatry, Indiana University School of Medicine,
and the Indianapolis VA Medical Center, Indianapolis, Indiana

Acknowledgement

This Brief Report series is derived from the roundtable meeting “Understanding the lifetime course of schizophrenia: a longitudinal perspective on neurobiology to promote better outcomes and recovery,” which was held October 15, 2013. The faculty acknowledges Healthcare Global Village for editorial assistance in developing the manuscripts.


Funding/Support

The meeting, manuscript preparation, and dissemination of this brief report series was supported by Otsuka America Pharmaceutical, Inc., and Lundbeck. All faculty received a fee for service from Otsuka America Pharmaceutical, Inc., and Lundbeck for participation in the meeting and preparation of the manuscripts.

​​​​​​​​​​​​​​​​​​​
 
​​​​​​​​​
Psychiatrist.com The Journal of Clinical Psychiatry The Primary Care Companion for CNS Disorders The CME Institute Neurology Knowledge Terms of Use Privacy Policy